Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure - CAESAR (a Randomized Controlled Trial)

NCT07023016 is registered in ClinicalTrials.gov with National Heart Institute, Egypt as lead sponsor.

NCT NCT07023016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07023016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure - CAESAR (a Randomized Controlled Trial)
Lead sponsor
National Heart Institute, Egypt
Phase
Phase 2/3
Overall status
Completed
Start date
November 1, 2023
Completion date
February 28, 2025
Enrollment
515 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure (adhf), chronic kidney disease (ckd)